MUNICH, Germany, 19 November 2024 - In a comprehensive Genomic Press Interview, distinguished psychiatrist Professor Peter Falkai suggests promising new directions in schizophrenia treatment through ...
A gene mutation linked to schizophrenia may cause the brain to cling to outdated beliefs by disrupting a key decision-making circuit. Scientists were able to reverse this effect in mice, suggesting a ...
Each of our cells holds a set of biological instructions (our genes). The creation and growth of cells and the proteins inside of them are activated by our genetics. As we grow during pregnancy, our ...
"Schizophrenia really is a thought disorder first and foremost," Nebraska Medicine psychiatrist Melissa O'Dell said. O'Dell ...
In a cross-sectional study, researchers compared oral microbiota profiles and cognitive test scores in patients with schizophrenia and healthy controls. Within the schizophrenia group, lower microbial ...
Patients with schizophrenia experience osteoporosis at rates far exceeding the general population, yet clinicians have lacked genetic explanations for this apparent relationship. Researchers headed by ...
The FDA on Thursday approved xanomeline and trospium chloride (Cobenfy) for schizophrenia in adults, the first new class of drug for the condition in more than 30 years. In contrast to antipsychotics ...
NBI-1117570 is an investigational oral, dual muscarinic M1/M4 selective receptor agonist discovered by Nxera advancing through clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results